Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2018

Open Access 01-03-2018 | Colorectal Cancer

Snapshot Study on the Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer

Authors: Robin D. Blok, MD, Gijsbert D. Musters, MD, PhD, Wernard A. A. Borstlap, MD, PhD, Christianne J. Buskens, MD, PhD, Wilhelmus A. Bemelman, MD, PhD, Pieter J. Tanis, MD, PhD, Collaborative Dutch Snapshot Research Group

Published in: Annals of Surgical Oncology | Issue 3/2018

Login to get access

Abstract

Background

Perineal wound complications are often encountered following abdominoperineal resection (APR). Filling of the pelvic space by omentoplasty (OP) might prevent these complications, but there is scant evidence to support its routine application.

Objective

The aim of this study was to evaluate the impact of OP on perineal wound complications.

Methods

All patients undergoing APR with primary perineal closure (PPC) for non-locally advanced rectal cancer in 71 Dutch centers in 2011 were selected from a cross-sectional snapshot study. Outcomes were compared between PPC with or without OP, which was based on variability in practice among surgeons.

Results

Of 639 patients who underwent APR for rectal cancer, 477 had a non-locally advanced tumor and PPC was performed. Of those, 172 (36%) underwent OP. Patients with OP statistically more often underwent an extralevator approach (32% vs. 14%). Median follow-up was 41 months (interquartile range 22–47). There were no significant differences with or without OP in terms of non-healing of the perineal wound at 30 days (47% vs. 48%), non-healing at the end of follow-up (9% vs. 5%), pelvic abscess (12% vs. 13%) or re-intervention for ileus (5% vs. 3%). Perineal hernia developed significantly more often after OP (13% vs. 7%), also by multivariable analysis (odds ratio 2.61, 95% confidence interval 1.271–5.364; p = 0.009).

Conclusions

In contrast to previous assumptions, OP after APR with PPC appeared not to improve perineal wound healing and seemed to increase the occurrence of perineal hernia. These findings question the routine use of OP for primary filling of the pelvic space.
Appendix
Available only for authorised users
Literature
1.
Musters GD, Buskens CJ, Bemelman WA, Tanis PJ. Perineal wound healing after abdominoperineal resection for rectal cancer: a systematic review and meta-analysis. Dis Colon Rectum. 2014;57(9):1129–39.CrossRefPubMed
2.
Bullard KM, Trudel JL, Baxter NN, Rothenberger DA. Primary perineal wound closure after preoperative radiotherapy and abdominoperineal resection has a high incidence of wound failure. Dis Colon Rectum. 2005;48(3):438–43.CrossRefPubMed
3.
Howell AM, Jarral OA, Faiz O, Ziprin P, Darzi A, Zacharakis E. How should perineal wounds be closed following abdominoperineal resection in patients post radiotherapy–primary closure or flap repair? best evidence topic (BET). Int J Surg. 2013;11(7):514–17.CrossRefPubMed
4.
Nilsson PJ. Omentoplasty in abdominoperineal resection: a review of the literature using a systematic approach. Dis Colon Rectum. 2006;49(9):1354–61.CrossRefPubMed
5.
6.
Dutch Snapshot Research Group. Benchmarking recent national practice in rectal cancer treatment with landmark randomized controlled trials. Colorectal Dis. 2017;19(6):O219–31.CrossRef
7.
Reggiani Bonetti L, Domati F, Farinetti A, Migaldi M, Manenti A. Radiotherapy-induced mesorectum alterations: histological evaluation of 90 consecutive cases. Scand J Gastroenterol. 2015;50(2):197–03.CrossRefPubMed
8.
Collins D, Hogan AM, O’Shea D, Winter DC. The omentum: anatomical, metabolic, and surgical aspects. J Gastrointest Surg. 2009;13(6):1138–46.CrossRefPubMed
9.
Doherty NS, Griffiths RJ, Hakkinen JP, Scampoli DN, Milici AJ. Post-capillary venules in the “milky spots” of the greater omentum are the major site of plasma protein and leukocyte extravasation in rodent models of peritonitis. Inflamm Res. 1995;44(4):169–77.CrossRefPubMed
10.
Van Vugt E, Van Rijthoven EA, Kamperdijk EW, Beelen RH. Omental milky spots in the local immune response in the peritoneal cavity of rats. Anat Rec. 1996;244(2):235–45.CrossRefPubMed
11.
Musters GD, Klaver CEL, Bosker RJI, et al. Biological mesh closure of the pelvic floor after extralevator abdominoperineal resection for rectal cancer: a multicenter randomized controlled trial (the BIOPEX-study). Ann Surg. 2017;265(6):1074–81.CrossRefPubMed
12.
Killeen S, Devaney A, Mannion M, Martin ST, Winter DC. Omental pedicle flaps following proctectomy: a systematic review. Colorectal Dis. 2013;15(11):e634–e45.CrossRefPubMed
13.
Klaver YL, Nienhuijs SW, Nieuwenhuijzen GA, Rutten HJ, de Hingh IH. Omentoplasty in rectal cancer surgery prolongs post-operative ileus. Int J Colorectal Dis. 2008;23(2):165–169.CrossRefPubMed
Metadata
Title
Snapshot Study on the Value of Omentoplasty in Abdominoperineal Resection with Primary Perineal Closure for Rectal Cancer
Authors
Robin D. Blok, MD
Gijsbert D. Musters, MD, PhD
Wernard A. A. Borstlap, MD, PhD
Christianne J. Buskens, MD, PhD
Wilhelmus A. Bemelman, MD, PhD
Pieter J. Tanis, MD, PhD
Collaborative Dutch Snapshot Research Group
Publication date
01-03-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 3/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6273-9

Other articles of this Issue 3/2018

Annals of Surgical Oncology 3/2018 Go to the issue

Thoracic Oncology

Perioperative Risk Calculator Predicts Long-Term Oncologic Outcome for Patients with Esophageal Carcinoma

Melanomas

Follow-Up Recommendations after Diagnosis of Primary Cutaneous Melanoma: A Population-Based Study in New South Wales, Australia

Gastrointestinal Oncology

Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC

Endocrine Tumors

STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro

Endocrine Tumors

Challenges Staging Neuroendocrine Tumors of the Pancreas, Jejunum and Ileum, and Appendix

Gastrointestinal Oncology

Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry